Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium, J Clin Invest, vol.119, pp.2702-2715, 2009. ,
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation, Neoplasia N Y N, vol.15, pp.335-382, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00815985
Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin, Oncogene, vol.29, pp.4225-4261, 2010. ,
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer, Breast Cancer Res BCR, vol.15, p.101, 2013. ,
Protein-based therapeutic approaches targeting death receptors, Cell Death Differ, vol.10, pp.117-140, 2003. ,
Death receptors: targets for cancer therapy, Exp Cell Res, vol.316, pp.887-99, 2010. ,
Death receptors, Essays Biochem, vol.39, pp.53-71, 2003. ,
A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death, Mol Cell, vol.47, pp.291-305, 2012. ,
Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model, Mol Cell, vol.47, pp.306-325, 2012. ,
Getting TRAIL back on track for cancer therapy, Cell Death Differ, vol.21, pp.1350-64, 2014. ,
BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane, Cell Death Differ, vol.18, pp.538-586, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00592286
Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis, Cell Death Differ, vol.21, pp.196-205, 2014. ,
Death receptor-ligand systems in cancer, cell death, and inflammation, Cold Spring Harb Perspect Biol, vol.5, p.8698, 2013. ,
FLIP as a therapeutic target in cancer, FEBS J, vol.285, pp.4104-4127, 2018. ,
Caspase-10 negatively regulates Caspase-8-mediated cell death, switching the response to CD95L in favor of NF-?B activation and cell survival, Cell Rep, vol.19, pp.785-97, 2017. ,
Co-operative and hierarchical binding of c-FLIP and Caspase-8: a unified model defines how c-FLIP isoforms differentially control cell fate, Mol Cell, vol.61, pp.834-883, 2016. ,
Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain, Cell Death Differ, vol.23, pp.681-94, 2016. ,
Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells, Gut, vol.60, pp.225-262, 2011. ,
C-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells, Biochem Pharmacol, vol.76, pp.1694-704, 2008. ,
c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells, Cancer Res, vol.67, pp.9425-9459, 2007. ,
C-FLIP: a key regulator of colorectal cancer cell death, Cancer Res, vol.67, pp.5754-62, 2007. ,
mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells, Mol Cell Biol, vol.25, pp.8809-8832, 2005. ,
cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy, Br J Haematol, vol.132, pp.560-70, 2006. ,
c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome, Br J Haematol, vol.128, pp.767-73, 2005. ,
Targeting the anti-apoptotic protein c-FLIP for Cancer therapy, Cancers, vol.3, pp.1639-71, 2011. ,
The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover, Cell, vol.124, pp.601-614, 2006. ,
Ubiquitinspecific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme, Cancer Res, vol.70, pp.5046-53, 2010. ,
Acquired resistance of ER-positive breast Cancer to endocrine treatment confers an adaptive sensitivity to TRAIL through posttranslational downregulation of c-FLIP, Clin Cancer Res Off J Am Assoc Cancer Res, vol.24, pp.2452-63, 2018. ,
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatininduced, p53-dependent ubiquitination of FLICE-like inhibitory protein, Oncogene, vol.29, pp.11-25, 2010. ,
Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells, Cancer Res, vol.68, pp.4511-4518, 2008. ,
Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells, Cell Death Differ, vol.17, pp.1354-67, 2010. ,
Neuregulin 1 allosterically enhances the antitumor effects of the noncompeting anti-HER3 antibody 9F7-F11 by increasing its binding to HER3, Mol Cancer Ther, vol.16, pp.1312-1335, 2017. ,
The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2-dependent ITCH/AIP4 activation, Oncotarget, vol.7, issue.24, pp.37013-37042, 2016. ,
Targeting HER3 using mono-and bispecific antibodies or alternative scaffolds, mAbs, vol.8, pp.1195-209, 2016. ,
Clinical development of HER3-targeting monoclonal antibodies: perils and progress, Cancer Treat Rev, vol.68, pp.111-134, 2018. ,
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models, Oncotarget, vol.5, pp.7138-7186, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01075330
The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X, J Biol Chem, vol.281, pp.38738-38785, 2006. ,
Activation of the E3 ubiquitin ligase itch through a phosphorylation-induced conformational change, Proc Natl Acad Sci, vol.103, pp.1717-1739, 2006. ,
USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability, Oncogene, vol.36, pp.458-70, 2017. ,
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy, Cell Death Dis, vol.5, p.1203, 2014. ,
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux, J Cell Sci, vol.122, pp.3330-3339, 2009. ,
Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway, EMBO J, vol.22, pp.3580-90, 2003. ,
IAPs and cell death, Curr Top Microbiol Immunol, vol.403, pp.95-117, 2017. ,
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma, EMBO Mol Med, vol.8, pp.851-62, 2016. ,
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma, Oncotarget, vol.6, pp.24823-24864, 2015. ,
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer, Oncotarget, vol.4, pp.1253-65, 2013. ,
ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells, Oncotarget, vol.5, pp.5138-52, 2014. ,
Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells, Cell Cycle Georget Tex, vol.11, pp.1455-67, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00961644
Examination of HER3 targeting in cancer using monoclonal antibodies, Proc Natl Acad Sci U S A, vol.112, pp.839-883, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02276327
USP8 is a novel target for overcoming gefitinib resistance in lung cancer, Clin Cancer Res Off J Am Assoc Cancer Res, vol.19, pp.3894-904, 2013. ,
Downregulation of epidermal growth factor receptor expression contributes to alpha-TEA's Proapoptotic effects in human ovarian Cancer cell lines, J Oncol, p.824571, 2010. ,
ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins, Cancer Res, vol.71, pp.538-587, 2011. ,
Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species, Cancer Res, vol.69, pp.6581-6590, 2009. ,
An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells, Cell Res, vol.19, pp.984-95, 2009. ,
Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways, Blood, vol.115, pp.5180-90, 2010. ,
BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response, Mol Cell, vol.51, pp.751-65, 2013. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations